Core revenue of $56.1 million exceeded Q1 guidance of $49.9 million Cash operating expense down 4% compared to Q1 2022 and down 24% versus Q4 2022 Completed strategic partnership with Givaudan on April 3 for $200 million upfront cash EMERYVILLE, Calif., May 9, 2023 /PRNewswire/ -- Amyris,...
News Ticker
- [ May 27, 2023 ] Senior Director, Head of Medical Affairs – Cargo Therapeutics – San Mateo, CA San Francisco Biotech Jobs
- [ May 27, 2023 ] Clinical Data Manager – Revolution Medicines – Redwood City, CA San Francisco Biotech Jobs
- [ May 27, 2023 ] Postdoc or Staff Computational Biologist: Quantitative Evolutionary Genomics and Ecology in Plants – Carnegie Institution – Stanford, CA San Francisco Biotech Jobs
- [ May 27, 2023 ] Research Assistant: Next Generation Sequencing and CRISPR in Plants – Carnegie Institution – Stanford, CA San Francisco Biotech Jobs
- [ May 27, 2023 ] Research Associate II, Analytical Development, Bioassays – Vir Biotechnology, Inc. – San Francisco, CA San Francisco Biotech Jobs
Copyright © 2023 Biotech Networks, LLC
